TARDBP and amyotrophic lateral sclerosis: Indeed, the presence of some cellular toxicity in PBMCs was shown by De Marco et al. (2010) [49] who determined that the cytoplasmic fraction of TDP-43 in circulating PBMCs of sporadic and familial ALS patients was increased.